Cystic Fibrosis Weekly Update

Contents:

Savara Closing Trial of Molgradex in Treating NTM Lung Infections in CF Patients

Sep 09, 2020 07:00 am | Forest Ray

Savara Pharmaceuticals is stopping its Phase 2a exploratory clinical study of Molgradex (molgramostim nebulizer solution) to treat nontuberculous mycobacterial (NTM) lung infection in people with cystic fibrosis (CF), the company announced in a press release. The decision to discontinue the open-label ENCORE trial (NCT03597347) stems from an inability to achieve the study’s primary outcome. That goal was to assess the effects of the therapy in converting NTM-positive […]
The post Savara Closing Trial of Molgradex in Treating NTM Lung Infections in CF Patients appeared first on Cystic Fibrosis News Today.

Listening to Both Sides of the Mask Debate

Sep 08, 2020 03:00 pm | Bailey Vincent

mask, body image, walk, pre-existing condition, perspective, slowing down

“I want to take my mask off.” I said these words to my daughters two days ago in a Barnes & Noble bookstore, even though I have pontificated novels to the contrary since this novel virus hit. In a world besieged by terms like “anti-masker” and “pro-mask,” I can’t help but feel I fall somewhere […]
The post Listening to Both Sides of the Mask Debate appeared first on Cystic Fibrosis News Today.

$10M Grants Will Fund New Research Seeking to Improve Transplant Outcomes

Sep 08, 2020 07:00 am | Marisa Wexler MS

A series of new research projects will seek to better understand how the immune system responds to transplanted organs, including the lungs. The goal is to find ways to increase the viability of organs after transplant, which could improve care for conditions like cystic fibrosis (CF). The projects are being funded by a $7.7 million […]
The post $10M Grants Will Fund New Research Seeking to Improve Transplant Outcomes appeared first on Cystic Fibrosis News Today.